TBEA(600089)2025-04-21 11:00Financial Performance - The company's operating revenue for Q1 2025 was CNY 2,335.73 million, a decrease of 0.79% compared to CNY 2,354.27 million in the same period last year[1] - Net profit attributable to shareholders was CNY 160.02 million, down 19.74% from CNY 199.38 million year-on-year[1] - Basic and diluted earnings per share were both CNY 0.3187, reflecting a decline of 19.76% compared to CNY 0.3972 in the previous year[1] - Net profit for Q1 2025 was approximately ¥1.66 billion, down 30.54% from ¥2.39 billion in Q1 2024[19] - Operating profit for Q1 2025 was approximately ¥2.09 billion, a decrease of 25.83% compared to ¥2.82 billion in Q1 2024[18] - The company achieved a gross profit margin of approximately 13.8% in Q1 2025, compared to 14.7% in Q1 2024, reflecting increased costs[16] Cash Flow - The net cash flow from operating activities decreased significantly by 57.80%, from CNY 249.59 million to CNY 105.33 million[1] - The net cash flow from operating activities for Q1 2025 was ¥1,053,310,781.67, a decrease of 57.8% compared to ¥2,495,879,057.10 in Q1 2024[23] - The company reported a net cash outflow from operating activities of ¥554,690,415.91 in Q1 2025, contrasting with a net inflow of ¥105,309,325.05 in Q1 2024[32] - Cash inflow from operating activities for Q1 2025 was approximately ¥27.68 billion, compared to ¥24.68 billion in Q1 2024, reflecting a growth of 12.19%[22] Assets and Liabilities - Total assets at the end of the reporting period increased by 2.74% to CNY 21,361.30 million from CNY 20,762.33 million at the end of the previous year[1] - The company's current assets totaled RMB 87.90 billion, up from RMB 83.88 billion, indicating an increase of about 4.0%[11] - Total liabilities increased to RMB 121.29 billion from RMB 117.64 billion, reflecting a growth of about 3.0%[13] - The total assets reached ¥57,459,816,567.31 as of March 31, 2025, compared to ¥56,937,718,530.67 at the end of 2024, indicating a growth of 0.9%[27] - Total liabilities as of March 31, 2025, were ¥26,725,874,772.09, a slight increase from ¥26,503,630,099.03 at the end of 2024[28] Shareholder Equity - Shareholders' equity attributable to the parent company rose by 2.92% to CNY 6,943.80 million from CNY 6,743.99 million at the end of the previous year[1] - The company's total equity attributable to shareholders increased to approximately ¥69.44 billion as of March 31, 2025, from ¥67.47 billion as of December 31, 2024[14] - The company's total equity increased to ¥30,733,941,795.22 as of March 31, 2025, from ¥30,434,088,431.64 at the end of 2024[29] Investment and Research - The company recognized non-recurring gains of CNY 82.06 million during the reporting period, primarily from asset disposals and government subsidies[4] - Research and development expenses increased to approximately ¥476.14 million in Q1 2025, up 29.49% from ¥367.70 million in Q1 2024[18] - Research and development expenses for Q1 2025 were ¥30,765,372.80, up from ¥21,320,995.09 in Q1 2024, indicating a focus on innovation[30] - The company reported a significant increase in investment income, reaching ¥3,651,489.08 in Q1 2025, compared to ¥842,760.00 in Q1 2024[30] Other Key Points - The company acquired a 67% stake in Fangchenggang Zhongsi Road New Materials Technology Co., Ltd., which was included in the consolidated financial statements[3] - The total number of ordinary shareholders at the end of the reporting period was 334,014[7] - The company has not disclosed any significant new strategies or product developments during the reporting period[9]